文献速递消化内镜

内镜医师指导护士给予平衡丙泊酚镇静在ASA III级患者中的安全性

Safety of endoscopist-directed nurse-administered balanced propofol sedation in patients with severe systemic disease (ASA class III).
PubMed 文献 · Gastrointest Endosc · 2020-12-10

共纳入18910例结肠镜和9178例胃镜,两组均无插管或死亡等主要不良事件,气道干预率低且组间无差异。结论认为EDNAPS在ASA III级患者常规门诊内镜检查中安全。

要点

  • ASA III级患者接受EDNAPS无插管或死亡等主要不良事件。
  • 气道干预率在ASA I/II与ASA III级患者间无差异。
  • EDNAPS可用于ASA III级患者常规门诊胃镜和结肠镜。

核心结论

  • EDNAPS在ASA I/II和ASA III级患者常规门诊内镜检查中均安全。

研究设计与样本

  • 排除住院操作、联合操作、ASA IV级或更高、操作开始时使用持续或双水平正压通气、以及非消化科医生执行的操作。
  • 按操作类型和ASA分级分层,ASA III级患者按年龄、性别和是否有fellow参与以3比1匹配比较。

主要发现

  • 结肠镜和胃镜操作中均无插管、需复苏或死亡等主要不良事件。
  • 任何气道干预、托下颌、口鼻咽 airway 或使用正压通气的比率在两种操作中均低,且ASA I/II与ASA III级患者间无差异。

关键数值与推荐

  • 主要不良事件定义为插管或死亡。
  • 次要不良事件定义为低氧、低血压、心动过缓或需要气道干预。

临床怎么用

  • 对于ASA III级患者行常规门诊胃镜或结肠镜,可考虑由内镜医师指导护士给予平衡丙泊酚镇静。

局限性

  • 回顾性研究设计。
  • 单中心数据。
  • 排除住院、联合操作及ASA IV级及以上患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The safety of endoscopist-directed nurse-administered propofol sedation (EDNAPS) has been demonstrated in low-risk patients (American Society of Anesthesiologists [ASA] class I and II). There are limited data regarding the safety of EDNAPS for endoscopic procedures in ASA class III patients. The purpose of this study was to determine the safety of EDNAPS for routine outpatient endoscopy in this population. METHODS: We retrospectively reviewed all outpatient EGDs and colonoscopies performed with EDNAPS at the University of Utah from January 2015 to November 2018. Exclusion criteria were inpatient procedures, combined procedures, ASA IV or higher, use of continuous or bilevel positive airway pressure at the start of the procedure, or procedures performed by a nongastroenterologist. Major adverse events were defined as intubation or death. Minor adverse events were defined as hypoxia, hypotension, bradycardia, or need for airway interventions. Patients were stratified by procedure type and ASA I/II status and were compared with patients with ASA III status and matched according to age, gender, and the involvement of a fellow in a 3 to 1 fashion. RESULTS: The final sample size was 18,910 colonoscopy procedures (17,205 patients) and 9178 EGD procedures (6827 patients). In both colonoscopy and EGD procedures, there were no major adverse events such as intubation, need for resuscitation, or death. The rates of any airway intervention, jaw thrust, oral nasal airway, or use of positive pressure ventilation were low in both procedure types and not different between ASA I/II and ASA III patients. CONCLUSION: EDNAPS is safe in both ASA I/II and ASA class III patients undergoing routine outpatient endoscopy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. McKenzie P, Fang J, Davis J, et al. Safety of endoscopist-directed nurse-administered balanced propofol sedation in patients with severe systemic disease (ASA class III). Gastrointest Endosc. 2020. PMID: 33309879. doi:10.1016/j.gie.2020.11.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。